Cite
APA Citation
Suleman, K., Mushtaq, A., Haque, E., Badran, A., Ajarim, D., Tweigeri, T., Elashwah, A., Shahin, A., Khan, K., & Alsayed, A. (n.d.). retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016. Breast, 44, S64–. http://access.bl.uk/ark:/81055/vdc_100080179681.0x00001e